WallStreetZenWallStreetZen

NASDAQ: PTIX
Protagenic Therapeutics Inc Stock Ownership - Who owns Protagenic Therapeutics?

OverviewEarningsDividendOwnership

Insider buying vs selling

Have Protagenic Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Alexander K. ArrowChief Financial Officer2023-10-128,000$0.81
$6.48kBuy

1 of 1

PTIX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PTIX insiders and whales buy or sell their stock.

PTIX Shareholders

What type of owners hold Protagenic Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Eagle Asset Management Inc9.45%419,324$628.99kInstitution
Alexander K. Arrow1.03%45,815$68.72kInsider
Vanguard Group Inc0.75%33,166$49.75kInstitution
Geode Capital Management LLC0.57%25,174$37.76kInstitution
Osaic Holdings Inc0.48%21,414$32.12kInstitution
Fny Investment Advisers LLC0.42%18,750$28.13kInstitution
State Street Corp0.31%13,812$20.72kInstitution
Tower Research Capital LLC Trc0.13%5,813$8.72kInstitution
Wells Fargo Company0.00%27$40.50Institution
Bank Of America Corp0.00%1$1.50Institution

1 of 2

PTIX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PTIX12.12%1.03%Net Buying
TFFP3.17%96.83%Net Buying
CVKD10.40%46.72%Net Buying
ADIL3.26%96.74%Net Buying
VIRI3.52%5.34%Net Buying
View Top Biotech Stocks

Protagenic Therapeutics Stock Ownership FAQ

Who owns Protagenic Therapeutics?

Protagenic Therapeutics (NASDAQ: PTIX) is owned by 12.12% institutional shareholders, 1.03% Protagenic Therapeutics insiders, and 86.85% retail investors. Alexander K. Arrow is the largest individual Protagenic Therapeutics shareholder, owning 45,815.00 shares representing 1.03% of the company. Alexander K. Arrow's Protagenic Therapeutics shares are currently valued at $68.72k.

If you're new to stock investing, here's how to buy Protagenic Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.